However, despite the supportive therapy, the patient developed cachexia, with a weight loss progressing up to 22.9% at the end of RT/CHRT (Table 1)—after a temporary reduction, the levels of 3HB and CRP started to rise again (the patient’s NMR spectra no. 9 and 10 in Fig. 3a fall into the outlier area, which is due to the increased ketone bodies, Fig. 3b) and decrease in PreALB (Table 1). The gene discussed is CRP; the disease is Cachexia.